Thiobutabarbital
Chemical compound
From Wikipedia, the free encyclopedia
Thiobutabarbital (Inactin, Brevinarcon) is a short-acting barbiturate derivative invented in the 1950s. It has sedative, anticonvulsant and hypnotic effects, and is still used in veterinary medicine for induction in surgical anaesthesia.[1]
Other namesThiobutabarbital, Inactin, Brevinarcon, 5-sec-Butyl-5-ethyl-2-thiobarbituric acid
ATC code
- none
| Clinical data | |
|---|---|
| Other names | Thiobutabarbital, Inactin, Brevinarcon, 5-sec-Butyl-5-ethyl-2-thiobarbituric acid |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.016.600 |
| Chemical and physical data | |
| Formula | C10H16N2O2S |
| Molar mass | 228.31 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |